PLx Pharma Proposes “GI-Safer” OTC Aspirin In New Drug Application
This article was originally published in The Pink Sheet Daily
Executive Summary
The firm files a rare new drug application for an OTC product, a formulation of aspirin and phosphatidylcholine designed to be more tolerable to the gastrointestinal tract. The involvement of OTC veterans Peter Mann and Michael Valentino on PLx’s board suggests strong market potential.